[1] |
Takada A, Ohmori K, Yoneda T, et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res, 1993, 53(2):354-361.
|
[2] |
Kannagi R. Carbohydrate antigen sialyl Lewis A:its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J, 2007, 30(3):189-209.
|
[3] |
Steinberg W. The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol, 1990, 85(4):350-355.
|
[4] |
沈剑虹,陆品相.血清CA199检测对消化道恶性肿瘤的临床意义.中国现代医学杂志, 2008, 18(20):3056-3057, 3065.
|
[5] |
Shibata K, Iwaki K, Kai S, et al. Increased levels of both carbohydrate antigen 19-9 and duke pancreatic monoclonal antigen type 2 reflect postoperative prognosis in patients with pancreatic carcinoma. Pancreas, 2009, 38(6):619-624.
|
[6] |
Sheen-Chen SM, Sun CK, Liu YW, et al. Extremely elevated CA19-9 in acute cholangitis. Dig Dis Sci, 2007, 52(11):3140-3142.
|
[7] |
李珂,姚炜,常虹,等.梗阻性黄疸224例分析.中国现代医学杂志, 2008, 18(22):3309-3312.
|
[8] |
揭育丽,梁伟娟.血清CA19-9对胰腺癌及胆道疾病临床诊断的价值.中国热带医学, 2009, 9(5):871-872.
|
[9] |
谭政良,雷萌.肝病患者血清糖类抗原CA199化学发光法检测的临床意义.中国现代医学杂志, 2003, 13(10):67-68.
|
[10] |
陈斌鸿,陈社安.血清CA125在肝硬化与肝癌诊断中的价值.江西医学检验, 2002, 20(6):329-330.
|
[11] |
刘栋,吴齐飞,刘昌,等.血清GGT,GGT/ALP及CA19-9检测在恶性梗阻性黄疸诊断中的价值.第四军医大学学报, 2009, 30(24):3079-3081.
|
[12] |
Wood B, Lo L, Cleary J, et al. Nutritional status in hospital inpatients: implications for nutritional support services. Aust N Z J Med, 1985, 15(4):435-441.
|
[13] |
Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg, 2002, 89(12):1525-1231.
|
[14] |
Heimbach JK, Gores GJ, Haddock MG, et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation, 2006, 82(12):1703-1707.
|
[15] |
Huang JL, Biehl TR, Lee FT, et al. Outcomes after resection of cholangiocellular carcinoma. Am J Surg, 2004, 187(5):612-617.
|
[16] |
Abdel Wahab M, Fathy O, Elghwalby N, et al. Resectability and prognostic factors after resection of hilar cholangiocarcinoma. Hepatogastroenterology, 2006, 53(67):5-10.
|
[17] |
王菲,孙学军,郑见宝,等. Ezrin蛋白在胆囊癌组织中的表达及其与血清CEA及CA19-9阳性率的关系.中国普外基础与临床杂志, 2010, 17(4):317-322.
|